Finance

Beta
Lists
603168:SHA
Zhejiang Shapuaisi Pharmaceutical Co Ltd
CNÂ¥5.46
+0.18%
(+0.010) 1D
Jun 9, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603168...
Open
CNÂ¥5.44
High
CNÂ¥5.58
Low
CNÂ¥5.35
Mkt. cap
2.04B
Avg. vol.
6.53M
Volume
5.69M
52-wk high
CNÂ¥9.09
52-wk low
CNÂ¥5.35
EPS
-CNÂ¥0.75
Shares outstanding
322.59M
No. of employees
1K
Open
CNÂ¥5.44
High
CNÂ¥5.58
Low
CNÂ¥5.35
Mkt. cap
2.04B
Avg. vol.
6.53M
Volume
5.69M
52-wk high
CNÂ¥9.09
52-wk low
CNÂ¥5.35
EPS
-CNÂ¥0.75
Shares outstanding
322.59M
No. of employees
1K
News stories
From sources across the web
About Zhejiang Shapuaisi Pharmaceutical Co Ltd
CEO-
Employees1.14K
FoundedJul 17, 2000
Headquarters-
SectorPharmaceutical industry
Websitezjspas.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
134.36M
114.54M
112.15M
98.52M
Cost of goods sold
53.47M
66.48M
104.99M
48.48M
Cost of revenue
53.47M
66.48M
104.99M
48.48M
Research and development expenses
2.53M
3.09M
10.34M
4.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49.57M
52.26M
44.72M
38.58M
Operating expense
52.98M
55.87M
62.85M
43.58M
Total operating expenses
106.45M
122.34M
167.84M
92.06M
Operating income
27.91M
-7.80M
-55.69M
6.46M
Other non operating income
324.58K
-1.14M
1.53M
-298.85K
EBT including unusual items
12.38M
3.94M
-265.30M
-25.81M
EBT excluding unusual items
15.16M
12.45M
-51.48M
4.32M
Income tax expense
-630.37K
-1.83M
1.06M
289.14K
Effective tax rate
-5.09%
-46.50%
-0.40%
-1.12%
Other operating expenses
2.06M
-3.86M
6.67M
6.62K
Net income
13.01M
5.77M
-266.35M
-26.10M
Net profit margin
9.68%
5.04%
-237.49%
-26.50%
Earnings per share
-
-
-
-
Interest and investment income
-
23.03M
5.71M
20.69K
Interest expense
-13.08M
-1.63M
-3.03M
-1.86M
Net interest expenses
-13.08M
21.40M
2.68M
-1.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
43.49M
8.18M
-39.60M
22.55M
Gain or loss from assets sale
-646.17K
646.17K
-903.28K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more